Restoring Dystrophin via Exon Skipping Strategies AOC 1044 – Mark Stahl, MD (Avidity Biosciences) BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.) DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics) ED051 – Michelle Mellion, MD (PepGen, Inc.) ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics) SRP-5051 – Teji Singh, MD (Sarepta Therapeutics) WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 30:00 Keynote: Resilience – PPMD 2024 Annual Conference 4 months ago 2024 PPMD Annual Conference,Conferences & Meetings 43:27 Current Approved Therapies Panel & Discussion (Pt. 2) – PPMD 2024 Annual Conference 4 months ago 2024 PPMD Annual Conference,Conferences & Meetings 57:45 Sleep & Behavior: How They Impact Each Other – PPMD 2024 Annual Conference 4 months ago 2024 PPMD Annual Conference,Conferences & Meetings 55:59 Decision Making around Steroids, Weight, and Nutrition – PPMD 2024 Annual Conference 4 months ago 2024 PPMD Annual Conference,Conferences & Meetings 47:28 Panel Conversation: The Little Things Matter – PPMD 2024 Annual Conference 4 months ago 2024 PPMD Annual Conference,Conferences & Meetings 36:59 OptimizeDMD: Moving the Dial in Endocrinology & Bone – PPMD 2024 Annual Conference 4 months ago 2024 PPMD Annual Conference,Conferences & Meetings 47:56 Research Row: Approaches to Alter Progression – PPMD 2024 Annual Conference 4 months ago 2024 PPMD Annual Conference,Conferences & Meetings 48:44 Clinical Trials: A Panel Discussion on the Developmental Path – PPMD 2024 Annual Conference 4 months ago 2024 PPMD Annual Conference,Conferences & Meetings «1234…25»Page 2 of 25
by: Parent Project Muscular Dystrophy
